-+ 0.00%
-+ 0.00%
-+ 0.00%

Outset Medical Q2 FY26 net loss narrows to $18 million; revenue rises 1% to $31.6 million

PUBT·08/06/2026 20:06:35
Listen to the news
Outset Medical Q2 FY26 net loss narrows to $18 million; revenue rises 1% to $31.6 million
  • Outset Medical posted Q2 2026 revenue of $31.6 million, up 1% year over year and up 14% sequentially.
  • Net loss narrowed to $18 million; GAAP loss per share improved to $0.97.
  • Gross margin expanded 4.2 percentage points to 42% as gross profit rose 12% to $13.3 million.
  • Signed a three-year $40 million agreement with HCA Healthcare to refresh its Tablo fleet across the health system.
  • Reiterated 2026 revenue outlook of $125 million-$130 million; expects full-year non-GAAP gross margin in the low-40% to mid-40% range.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outset Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608061601PRIMZONEFULLFEED9804967) on August 06, 2026, and is solely responsible for the information contained therein.